ORPHAN MEDICAL INC
Healthcare · Pharmaceutical Preparations · MN · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Insider transactions
SEC Form 4 · most recent1 acquisitions0 disposalsnet +7,500 shares · last 1
| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Reardan Dayton TOfficer — Vice President | Mar 9, 2005 | Option exercise | 7,500 | $5.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Other material eventJun 22, 2005
- Other material eventMay 25, 2005
- Results of operationsApr 27, 2005
- Entered a material agreement · Regulation FD disclosureApr 20, 2005
- Results of operationsFeb 22, 2005
- Results of operationsOct 21, 2004
- Item 12Jul 22, 2004
- Item 5May 24, 2004
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 15, 2006
- 15-12GJun 24, 2005
- 8-KJun 22, 2005
- 8-KMay 25, 2005
- DEFM14AMay 23, 2005
- 10-QMay 10, 2005
- PREM14AMay 10, 2005
- SC 13DSCHEDULE 13DMay 6, 2005
- SC 13DSCHEDULE 13DMay 6, 2005
- SC 13DSCHEDULE 13DMay 6, 2005
- SC 13DSCHEDULE 13DMay 6, 2005
- 3May 6, 2005
- 10-K/AMay 2, 2005
- SC 13DApr 28, 2005
- SC 13D/AAMENDMENT NO.3 TO SCHEDULE 13DApr 28, 2005
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.